CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

Warning

This publication doesn't include Institute of Computer Science. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	BRYJA Vítězslav KAUCKÁ Markéta PLEVOVÁ Karla PAVLOVÁ Šárka POSPÍŠILOVÁ Šárka KOZUBÍK Alois
Year of publication	2016
Type	Patent
MU Faculty or unit	Central European Institute of Technology
Publisher	European patent Office
State	Germany
Patent's number	EP2882437 (B1)
web	https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20161214&DB=&locale=&CC=EP&NR=2882437B1&KC=B1&ND=1#
Description	The invention relates to inhibitors of casein kinase 1 for use in the treatment of B-cell chronic lymphocytic leukemia.
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies Úloha nekanonické Wnt signalizace v molekulární patogenezi chronické lymfocytární leukémie Molekulární mechanismy nekanonické Wnt signalizace v leukémii